Inhalation Anesthesia Market share to reach $1.6bn by 2024

1
Inhalation Anesthesia Market to grow at 3.5 CAGR
from 2016 to 2024 Global Market Insights Inc.
2
Key Insights from Inhalation Anesthesia Market

• Global Market Insights, Inc. says, Inhalation
  Anesthesia Market size is set to exceed USD 1.6
  billion by 2024.
• Rising number of geriatric population coupled
  with increasing number of chronic diseases such
  as cancer, cardiovascular, neurological, and
  respiratory disorders and introduction of
  advanced anesthesia will offer lucrative growth
  opportunities for the inhalation anesthesia
  market growth.
• Increasing number of emergency surgeries driving
  the count of hospital admissions coupled with
  favorable private and public insurance will drive
  the inhalation anesthesia market.
• Adverse side effects during recovery, procedure
  or surgery, or wearing off anesthesia coupled
  with effect like intraoperative discomfort,
  hypotension, post-lumbar-puncture headache, and
  potential for neurologic and cardiac toxicity
  from anesthetics may hamper the inhalation
  anesthesia market growth.

3
Continued...

• Sevoflurane segment accounted for the highest
  revenue share in 2016 and will grow at a
  significant rate over the forecast period owing
  to growing use in both maintenance and induction.
• U.S. market was valued over USD 488 million in
  2016 and will grow significantly over the coming
  years.
• Germany accounted for highest revenue share in
  the region, owing to increasing chronic
  conditions associated with elderly population
  coupled with adoption rate of inhalation
  anesthesia.
• Some of the companies operating in market are
  Abbott, Baxter International, Piramal, Lunan
  Pharmaceutical, Hikma Pharmaceuticals and
  Halocarbon Products.

4
U.S. Inhalation Anesthesia Market, By Product,
2013 - 2024 (USD Million)

5

Browse Full Market Research Report On
Inhalation Anesthesia Market _at_ http//bit.ly/2egy4
pA Request for a Sample of this Research
Report _at_ https//www.gminsights.com/request-sample
/detail/704 https//www.gminsights.com/request-sa
mple/detail/49
6
360 Analysis

• Product Analysis
• Sevoflurane dominated inhalation anesthesia
  market in 2016. The growth is attributed to high
  preference for sevoflurane and suitable for
  children and adults for maintenance as well as
  induction. Moreover, associated characteristics
  such as, low flammability, dearth of annoyance to
  airway passages, intrinsic stability.
• Regional Analysis
• U.S. inhalation anesthesia market accounted for
  largest regional share in 2016. Increasing number
  of plastic surgeries along with rising prevalence
  of chronic lower respiratory disease will fuel
  adoption of inhalation anesthesia.
• Competitive Market Share
• Some of the prominent players in inhalation
  anesthesia market are Baxter International, Hikma
  Pharmaceuticals, Mylan, Eisai, Halocarbon
  Products, Abbott, Piramal and Lunan
  Pharmaceutical.

7
Stay In Touch Website www.gminsights.com Soci
al Media